Publications

A selection of recent publications

Farhat R, Séron K, Ferlin J, Fénéant L, Belouzard S, Goueslain L, Jackson CL, Dubuisson J, Rouillé Y. (2016) Identification of class II ADP-ribosylation factors as cellular factors required for hepatitis C virus replication. Cell Microbiol, in press.

Callens N, Brügger B, Bonnafous P, Drobecq H, Gerl MJ, Krey T, Roman-Sosa G, Rümenapf T, Lambert O, Dubuisson J, Rouillé Y. (2016) Morphology and molecular composition of purified bovine viral diarrhea virus envelope. PLoS Pathog., in press.

Xu Y, Martinez P, Séron K, Luo G, Allain F, Dubuisson J, Belouzard S. (2015) Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans. J Virol, 89, 3846-3858.

Fénéant L, Potel J, François C, Sané F, Douam F, Bélouzard S, Calland N, Vausselin T, Rouillé Y, Descamps V, Baumert T, Duverlie G, Lavillette D, Hober D, Dubuisson J, Wychowski C, Cocquerel L. (2015) New insights into the understanding of hepatitis C virus entry and cell-to-cell transmission by using the ionophore Monensin A. J Virol, 89, 8346-8364.

Falson P, Bartosch B, Alsaleh K, Tews BA, Loquet A, Ciczora Y, Riva L, Montigny C, Montpellier C, Duverlie G, Pécheur EI, le Maire M, Cosset FL, Dubuisson J, Penin F. (2015) Hepatitis C virus envelope glycoprotein E1 forms trimers at the surface of the virion. J Virol, 89, 10333-10346.

Calland N, Sahuc ME, Belouzard S, Pène V, Bonnafous P, Mesalam AA, Deloison G, Descamps V, Sahpaz S, Wychowski C, Lambert O, Brodin P, Duverlie G, Meuleman P, Rosenberg AR, Dubuisson J, Rouillé Y, Séron K. (2015) Polyphenols inhibit hepatitis C virus entry by a new mechanism of action. J Virol, 89, 10053-10063.

Lavie M, Sarrazin S, Montserret R, Descamps V, Baumert T, Duverlie G, Séron K, Penin F, Dubuisson J. (2014) Identification of conserved residues in HCV envelope glycoprotein E2 modulating virus dependence on CD81 and SRB1 entry factors. J. Virol., 88, 10584-10597

Vausselin T, Calland N, Belouzard S, Descamps V, Douam F, Helle F, François C, Lavillette D, Duverlie G, Wahid A, Fénéant L, Cocquerel L, Guérardel Y, Wychowski C, Biot C, Dubuisson J. (2013) The antimalarial ferroquine is an inhibitor of hepatitis C virus. Hepatology, 58, 86-97.

Anjum S, Wahid A, Afzal MS, Albecka A, Alsaleh K, Tahir A, Baumert T, Wychowski C, Qadri I, Penin F, Dubuisson J. (2013) Glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization. J. Infect. Dis., 208, 1888-1897.

Wahid A, Helle, F, Descamps V, Duverlie G, Penin F, Dubuisson J. (2013) Disulfide bonds in HCV glycoprotein E1 control the assembly and entry functions of E2 glycoprotein. J Virol, 87, 1605-1617.

Potel J, Rassam P, Montpellier C, Kaestner L, Werkmeister E, Tews BA, Couturier C, Popescu CI, Baumert T, Rubinstein E, Dubuisson J, Milhiet PE, Cocquerel L. (2013) EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry. Cell. Microbiol., 15, 1234–1252.

Calland N, Albecka A, Belouzard S, Wychowski C, Duverlie G, Descamps V, Hober D, Dubuisson J, Rouillé Y, Séron K. (2012) (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology, 55, 720-729.

Albecka A, Belouzard S, Op de Beeck A, Descamps V, Goueslain L, Bertrand-Michel J, Tercé F, Duverlie G, Rouillé Y, Dubuisson J. (2012) Role of LDL receptor in the hepatitis C virus life cycle. Hepatology, 55, 998-1007.

Albecka A, Montserret R, Krey T, Tarr AW, Diesis E, Ball JK, Descamps V, Duverlie G, Rey F, Penin F, Dubuisson J. (2011) Identification of new functional regions in hepatitis C virus envelope glycoprotein E2. J Virol, 85, 1777-1792.

Popescu CI, Callens N, Trinel D, Roingeard P, Moradpour D, Descamps V, Duverlie G, Penin F, Héliot L, Rouillé Y, Dubuisson J. (2011) NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly. PLoS Pathog, 7, e1001278.

Montpellier C, Tews B, Proitrimole J, Rocha-Perugini V, D’Arienzo V, Potel J, Zhang XA, Rubinstein E, Dubuisson J, Cocquerel L. (2011) Biochemical and functional characterization of CD81 interaction with two of its partners, EWI-2 and EWI-2wint. J Biol Chem, 286, 13954-13965.

Meuleman P, Albecka A, Belouzard S, Vercauteren K, Verhoye L, Wychowski C, Leroux-Roels G, Palmer KE, Dubuisson J. (2011) Griffithsin has antiviral activity against hepatitis C virus. Antimicrob Agents Chemother. 55, 5159-5167.

Goueslain L, Alsaleh K, Horrelou P, Roingeard P, Descamps V, Duverlie G, Ciczora Y, Wychowski C, Dubuisson J, Rouillé Y. 2010. Identification of GBF1 as a cellular factor required for HCV RNA replication. J Virol, 84, 773-787.

Vieyres G, Thomas X, Descamps V, Duverlie G, Patel AH, Dubuisson J. (2010) Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J Virol, 84, 10159-10168.

Helle F, Vieyres G, Elkrief L, Popescu CI, Wychowski C, Descamps V, Castelain S, Roingeard P, Duverlie G, Dubuisson J. (2010) Role of N-linked glycans in the functions of HCV envelope proteins incorporated into infectious virions. J Virol, 84, 11905-11915.

Cette note est également disponible en: Anglais